about
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?Dose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiolSynergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liverSelective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbitalDose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpointsPolychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessmentEpigenetic mechanisms of chemical carcinogenesis.An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk.Multiple end point procedure to evaluate risk from pesticides.Promotion of hepatic preneoplastic lesions in male B6C3F1 mice by unleaded gasolineRole of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines.Growth-related alterations during liver carcinogenesis: effect of promotersAromatic amines in experimental cancer research: tissue-specific effects, an old problem and new solutions.Pathobiology of chemical hepatocarcinogenesis: recent progress and perspectives. Part II. Metabolic and molecular changes.Age-related changes in carcinogen metabolism.Cell proliferation and apoptosis in normal liver and preneoplastic fociEnhancement of tumor growth by drugs with some common molecular actions.Concepts of cell death and application to carcinogenesis.Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment.Association between responsiveness to phenobarbital induction of CYP2B1/2 and 3A1 in rat hepatic hyperplastic nodules and their zonal origin.Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane.Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.No inhibition of gamma-glutamyl transpeptidase-positive foci by vitamin E with or without phenobarbital.Expression of the lung resistance-related protein in human and rat hepatocarcinogenesis.Studies on the mechanism of the acute and carcinogenic effects of N-nitrosodimethylamine on mink liver.Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes.Dose-dependent biphasic effects of phenobarbital on growth and differentiation of primary culture rat hepatocytes.Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens.Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
P2860
Q24554410-6EBCEA98-5E8C-4594-B50F-7AAC8CC92559Q28334140-A85CF4EE-FA1F-4F17-ABBF-80503130103CQ28340447-A4F7D6DF-0D19-4003-8ABC-EDC53BC90774Q28369200-37D8F4D4-E44A-421E-97E4-9CD97BCB709DQ28369622-90765BD1-0C2B-4CC6-8FDA-8F00993A69CDQ29615426-F065D964-B68D-4478-B370-2795DF3D6F51Q34158314-85E2C4D4-28E6-4115-8BFD-1B9B68F9B086Q34660156-651B978E-67F8-4D18-A569-04BBBFBC691DQ34734778-8DB734CF-2DEC-412A-B6AC-DB183EEDE8FCQ34857299-A51BB885-6E19-46AA-85C2-40395F005E8DQ34864467-6D7AE7F3-83D7-4202-9B60-6E215C1691ECQ35034023-ED9C5C9A-A5E5-4E32-B38E-FE42FB0B5159Q35034066-0F69A81F-168F-4AEC-A249-A1A1EE05A651Q36799523-C111F854-DC7A-44BF-BA84-067729DA4107Q37576254-965ACA18-E5AF-44B8-A45E-6FA9D06CF531Q39752095-14DAF4BD-B3DB-42E8-A64F-7F131F6AE814Q40662457-F15609DC-489D-41C2-B1A6-BE21E160A5CEQ40995487-50CB17AD-B615-4394-AC15-8165FCC338F0Q41376328-8A0B944B-2D07-44E7-8F26-1FB2524DE61CQ41623622-BC7AE9E6-E988-40F1-AEC1-474186C4DF2FQ41869378-B1467A26-8DA0-460A-826B-0DB5906838C7Q42275544-6F9E1B97-AC77-4150-B85B-18FDEC413918Q42496615-2142BB71-55A2-44D2-ADD0-01420B21E0D1Q42549972-83370433-0EDD-4420-BC9B-4D44A20C2BE3Q44180688-50FFE47D-4A85-48AD-8816-A730EAB80688Q44311795-5064A560-2007-43CD-9BCC-C16487FAEB99Q44359179-306901FF-1421-46CB-A8E3-CBE3F0CD4EC5Q49613960-17BB50F1-8301-4065-9B38-599657784CF0Q49953739-7188229F-5BBA-40B9-B716-1CC98C5A79A1Q53511527-B0A681BD-F99F-481E-99E9-23539688BA51
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Tumor promotion in the liver.
@en
Tumor promotion in the liver.
@nl
type
label
Tumor promotion in the liver.
@en
Tumor promotion in the liver.
@nl
prefLabel
Tumor promotion in the liver.
@en
Tumor promotion in the liver.
@nl
P2860
P356
P1476
Tumor promotion in the liver.
@en
P2093
R Schulte-Hermann
P2860
P2888
P304
P356
10.1007/BF00290879
P577
1985-08-01T00:00:00Z